Selective androgen receptor modulators:in vitroandin vivometabolism and analysis
- 24 July 2013
- journal article
- research article
- Published by Taylor & Francis in Food Additives & Contaminants: Part A
- Vol. 30 (9) , 1517-1526
Abstract
For future targeted screening in National Residue Control Programmes, the metabolism of seven SARMs, from the arylpropionamide and the quinolinone classes, was studied in vitro using S9 bovine liver enzymes. Metabolites were detected and identified with ultra-performance liquid chromatography (UPLC) coupled to time-of-flight mass spectrometry (ToF-MS) and triple quadrupole mass spectrometry (QqQ-MS). Several metabolites were identified and results were compared with literature data on metabolism using a human cell line. Monohydroxylation, nitro-reduction, dephenylation and demethylation were the main S9 in vitro metabolic routes established. Next, an in vivo study was performed by oral administration of the arylpropionamide ostarine to a male calf and urine samples were analysed with UPLC-QToF-MS. Apart from two metabolites resulting from hydroxylation and dephenylation that were also observed in the in vitro study, the bovine in vivo metabolites of ostarine resulted in glucuronidation, sulfation and carboxylation, combined with either a hydroxylation or a dephenylation step. As the intact mother compounds of all SARMs tested are the main compounds present after in vitro incubations, and ostarine is still clearly present in the urine after the in vivo metabolism study in veal calves, the intact mother molecules were selected as the indicator to reveal treatment. The analytical UPLC-QqQ-MS/MS procedure was validated for three commercially available arylpropionamides according to European Union criteria (Commission Decision 2002/657/EC), and resulted in decision limits ranging from 0.025 to 0.05 µg l–1 and a detection capability of 0.025 µg l–1 in all cases. Adequate precision and intra-laboratory reproducibility (relative standard deviation below 20%) were obtained for all SARMs and the linearity was 0.999 for all compounds. This newly developed method is sensitive and robust, and therefore useful for confirmation and quantification of SARMs in bovine urine samples for residue control programmes and research purposes.Keywords
This publication has 12 references indexed in Scilit:
- SARM-S4 and metabolites detection in sports drug testing: A case reportForensic Science International, 2011
- SERMs and SARMs: Detection of their activities with yeast based bioassaysThe Journal of Steroid Biochemistry and Molecular Biology, 2010
- Detection of the arylpropionamide‐derived selective androgen receptor modulator (SARM) S‐4 (Andarine) in a black‐market productDrug Testing and Analysis, 2009
- Evidence of the indirect hormonal activity of prohormones using liver S9 metabolic bioactivation and an androgen bioassayAnalytical and Bioanalytical Chemistry, 2008
- Mass spectrometry of selective androgen receptor modulatorsJournal of Mass Spectrometry, 2008
- Aryl-Propionamide-Derived Selective Androgen Receptor Modulators: Liquid Chromatography-Tandem Mass Spectrometry Characterization of the in Vitro Synthesized Metabolites for Doping Control PurposesDrug Metabolism and Disposition, 2008
- Screening for 2‐quinolinone‐derived selective androgen receptor agonists in doping control analysisRapid Communications in Mass Spectrometry, 2007
- Expanding the therapeutic use of androgens via selective androgen receptor modulators (SARMs)Drug Discovery Today, 2007
- Therapeutic potential of the SARMs: revisiting the androgen receptor for drug discoveryExpert Opinion on Investigational Drugs, 2006
- Screening for metabolically stable aryl‐propionamide‐derived selective androgen receptor modulators for doping control purposesRapid Communications in Mass Spectrometry, 2006